MUSC HEALTH CHESTER MEDICAL CENTER
1. Target Overview & Investment Thesis
MUSC HEALTH CHESTER MEDICAL CENTER is a 16-bed safety-net/medicaid heavy in CHESTER, SC with $56.5M in net patient revenue and a -18.1% operating margin. The hospital serves a payer mix of 17.8% Medicare, 23.4% Medicaid, and 58.8% commercial.
Thesis: Turnaround. Our ML models identify $4.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.1% to -10.7% (+736bps).
| Net Revenue HCRIS | $56.5M |
| Current EBITDA COMPUTED | $-10.2M |
| Operating Margin COMPUTED | -18.1% |
| Occupancy HCRIS | 83.5% |
| Revenue / Bed COMPUTED | $3.5M |
| Net-to-Gross HCRIS | 24.1% |
| Distress Probability ML | 40.5% |
2. Market Context & Competitive Position
SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -18.1% places it below the state median. Among 9 size-comparable peers (8-32 beds), the median margin is -13.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-32), prioritizing same-state peers. 9 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MUSC HEALTH CHESTER MEDICAL CE (Target) | SC | 16 | $56.5M | -18.1% |
| CHEROKEE MEDICAL CENTER | SC | 25 | $61.2M | 8.3% |
| ABBEVILLE AREA MEDICAL CENTER | SC | 25 | $43.0M | -17.4% |
| UNION MEDICAL CENTER | SC | 15 | $30.0M | 4.3% |
| HAMPTON REGIONAL MEDICAL CENTE | SC | 32 | $24.0M | -21.2% |
| WILLIAMSBURG REGIONAL HOSPITAL | SC | 25 | $22.5M | -13.7% |
| EDGEFIELD COUNTY HEALTHCARE | SC | 25 | $15.5M | -12.4% |
| REGENCY HOSPITAL OF GREENVILLE | SC | 32 | $14.6M | -3.1% |
| ALLENDALE COUNTY HOSPITAL | SC | 25 | $13.3M | -33.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $687K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $36K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-10.2M |
| + RCM Uplift | +$4.2M |
| Pro Forma EBITDA | $-6.1M |
| Current Margin | -18.1% |
| Pro Forma Margin | -10.7% |
| WC Released (1x) | $2.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-15.7M | $-25.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-15.7M | $-33.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-14.1M | $-24.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-14.1M | $-31.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-17.3M | $-41.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-17.3M | $-51.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (23.4%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 9 hospitals with 8-32 beds
- Same-state prioritization (n=10)
- Comp margins: P25=-21.2% / P50=-13.7% / P75=-3.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.